SNCA 3′UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder

Neurological Sciences

Volumn 38, Issue 7, 2017, Pages 1233-1240

  Toffoli, M ^a   Dreussi, E ^b   Cecchin, E ^b   Valente, M ^a,c   Sanvilli, N ^a   Montico, M ^b   Gagno, S ^b   Garziera, M ^b   Polano, M ^b   Savarese, M ^d   Calandra Buonaura, G ^e   Placidi, F ^f   Terzaghi, M ^g   Toffoli, G ^b   Gigli, G L ^a,c  

^a UNIVERSITY OF UDINE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Alpha synuclein; Genetic variants; Parkinson s disease; RBD; REM sleep behavior disorder; SNCA

Indexed keywords

ALPHA SYNUCLEIN; GENOMIC DNA; MICRORNA; SNCA PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARASOMNIA; PARKINSON DISEASE; PROTEIN BINDING; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; COMPLICATION; GENETIC VARIATION; GENETICS; METABOLISM; MIDDLE AGED;

3' UNTRANSLATED REGIONS; AGED; ALPHA-SYNUCLEIN; FEMALE; GENE EXPRESSION; GENETIC VARIATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REM SLEEP BEHAVIOR DISORDER;

EID: 85017433273     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-017-2945-2     Document Type: Article

References (28)

1. AASM (2005) ICSD-II: International Classification of Sleep Disorders, 2nd edn (ICSD-2): diagnostic and coding manual.
2. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9:293–308
3. Dorsey ER, Constantinescu R, Thompson JP et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384–386. doi:10.1212/01.wnl.0000247740.47667.03
4. Howell MJ, Schenck CH (2015) Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 72:707–712. doi:10.1001/jamaneurol.2014.4563
5. Fuchs J, Tichopad A, Golub Y et al (2008) Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J 22:1327–1334. doi:10.1096/fj.07-9348com
6. Pals P, Lincoln S, Manning J et al (2004) Alpha-synuclein promoter confers susceptibility to Parkinson’s disease. Ann Neurol 56:591–595. doi:10.1002/ana.20268
7. Satake W, Nakabayashi Y, Mizuta I et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41:1303–1307. doi:10.1038/ng.485
8. Simón-Sánchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312. doi:10.1038/ng.487
9. Tan L, Yu J-T, Tan L (2015) Causes and consequences of microRNA dysregulation in neurodegenerative diseases. Mol Neurobiol 51:1249–1262. doi:10.1007/s12035-014-8803-9
10. Mouradian MM (2012) MicroRNAs in Parkinson’s disease. Neurobiol Dis 46:279–284. doi:10.1016/j.nbd.2011.12.046
11. Hughes A, Daniel S (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol … 1992.
12. Cardo LF, Coto E, de Mena L et al (2012) A search for SNCA 3′ UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson’s disease. J Mol Neurosci 47:425–430. doi:10.1007/s12031-011-9669-1
13. Hadjigeorgiou GM, Xiromerisiou G, Gourbali V et al (2006) Association of alpha-synuclein Rep1 polymorphism and Parkinson’s disease: influence of Rep1 on age at onset. Mov Disord 21:534–539. doi:10.1002/mds.20752
14. Maraganore DM, de Andrade M, Elbaz A et al (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296:661–670. doi:10.1001/jama.296.6.661
15. 2 UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci Lett 461:196–201. doi:10.1016/j.neulet.2009.06.034.A
16. Nomura T, Inoue Y, Kagimura T et al (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713. doi:10.1016/j.sleep.2011.01.015
17. Bjørnarå KA, Dietrichs E, Toft M (2014) Clinical features associated with sleep disturbances in Parkinson’s disease. Clin Neurol Neurosurg 124:37–43. doi:10.1016/j.clineuro.2014.06.027
18. Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–9A. doi:10.5664/jcsm.2340
19. Mizuta I, Satake W, Nakabayashi Y et al (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson’s disease. Hum Mol Genet 15:1151–1158. doi:10.1093/hmg/ddl030
20. Myhre R, Toft M, Kachergus J et al (2008) Multiple alpha-synuclein gene polymorphisms are associated with Parkinson’s disease in a Norwegian population. Acta Neurol Scand 118:320–327. doi:10.1111/j.1600-0404.2008.01019.x
21. Mueller JC, Fuchs J, Hofer A et al (2005) Multiple regions of alpha-synuclein are associated with Parkinson’s disease. Ann Neurol 57:535–541. doi:10.1002/ana.20438
22. McCarthy JJ, Linnertz C, Saucier L et al (2011) The effect of SNCA 3′ region on the levels of SNCA-112 splicing variant. Neurogenetics 12:59–64. doi:10.1007/s10048-010-0263-4
23. Auton A, Abecasis GR, Altshuler DM et al (2015) A global reference for human genetic variation. Nature 526:68–74. doi:10.1038/nature15393
24. Schmitt I, Wüllner U, van Rooyen JP et al (2012) Variants in the 3’UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression. Eur J Hum Genet 20:1265–1269. doi:10.1038/ejhg.2012.84
25. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46:388–393
26. Iranzo A, Molinuevo JL, Santamaría J et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577
27. Postuma R, Gagnon J, Vendette M (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology
28. Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291. doi:10.1038/nature19057